Enforcement Report - Week of May 24, 2023
“The company’s Maharashtra site found in compliance to WHO good manufacturing practices (GMPs) for Pyrazinamide APIMF158 and Sulfadoxine APIMF234 active pharmaceutical ingredients (APIs),” Anuh Pharma said in a release.
Anuh Pharma on Thursday said that the World Health Organisation (WHO) has suspended its products – Pyrazinamide and Sulfadoxine – from prequalified list of active pharmaceutical ingredients (API).
Anuh Pharma LTD fails EDQM Inspection